# AZA Combined With NAC for PIT After HSCT

> **NCT05126004** · PHASE2 · NOT_YET_RECRUITING · sponsor: **The First Affiliated Hospital of Soochow University** · enrollment: 100 (estimated)

## Conditions studied

- Thrombocytopenia, Isolated
- Stem Cell Transplant Complications

## Interventions

- **DRUG:** Azacitidine
- **DRUG:** N Acetyl L Cysteine

## Key facts

- **NCT ID:** NCT05126004
- **Lead sponsor:** The First Affiliated Hospital of Soochow University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2021-12-01
- **Primary completion:** 2024-06-30
- **Final completion:** 2026-06-30
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2021-11-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05126004

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05126004, "AZA Combined With NAC for PIT After HSCT". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05126004. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*